Selected article for: "clinical stability and severe pneumonia"

Author: Groeneveld, Geert H; van der Reyden, Tanny J; Joosten, Simone A; Bootsma, Hester J; Cobbaert, Christa M; de Vries, Jutte J C; Kuijper, Ed J; van Dissel, Jaap T
Title: Non-lytic antibiotic treatment in community-acquired pneumococcal pneumonia does not attenuate inflammation: the PRISTINE trial
  • Document date: 2019_5_18
  • ID: 19ueli6e_60
    Snippet: Strategies to dampen the inflammatory response in pneumonia have so far primarily focused on corticosteroids. Corticosteroid therapy has been demonstrated to result in shorter times to clinical stability and limited shortening of hospital stays in patients with non-severe community-acquired pneumonia. Some studies in adults with severe disease have shown a reduction in mortality. The quality of these studies is moderate. In all studies, corticost.....
    Document: Strategies to dampen the inflammatory response in pneumonia have so far primarily focused on corticosteroids. Corticosteroid therapy has been demonstrated to result in shorter times to clinical stability and limited shortening of hospital stays in patients with non-severe community-acquired pneumonia. Some studies in adults with severe disease have shown a reduction in mortality. The quality of these studies is moderate. In all studies, corticosteroid therapy increased the risk of hyperglycemia. 38 Therefore, corticosteroids are not included in current treatment guidelines. 7, 8 Alternative therapeutic options should be explored to attenuate the inflammation.

    Search related documents:
    Co phrase search for related documents
    • clinical stability and hospital stay: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
    • clinical stability and inflammatory response: 1, 2
    • community acquire and inflammatory response: 1
    • community acquire pneumonia and inflammatory response: 1
    • corticosteroid therapy and hospital stay: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • corticosteroid therapy and inflammation attenuate: 1
    • corticosteroid therapy and inflammatory response: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18
    • corticosteroid therapy and mortality reduction: 1, 2, 3, 4, 5
    • hospital stay and hyperglycemia risk: 1, 2
    • hospital stay and inflammatory response: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • hospital stay and mortality reduction: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • hospital stay and mortality reduction show: 1, 2
    • hyperglycemia risk and inflammatory response: 1
    • hyperglycemia risk and mortality reduction: 1, 2
    • inflammation attenuate and mortality reduction: 1
    • inflammatory response and mortality reduction: 1, 2, 3, 4, 5, 6, 7, 8, 9
    • inflammatory response and mortality reduction show: 1